Prednisone Acetate Tablets

DRUG9 trials

Sponsors

Jiang lindi, Henan University of Traditional Chinese Medicine, Hongqian Guo, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

AbirateroneAdvanced Prostate CancerHenoch-Schönlein Purpura NephritisMetastatic Castration-resistant Prostate CancerNeoadjuvant Therapy \ High Risk Prostate Cancer \ DocetaxelOligometastatic Prostate CancerPreviously Untreated Peripheral T-Cell LymphomaProstate Cancer

Phase 1

Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment

Henan University of Traditional Chinese MedicineHenoch-Schönlein Purpura Nephritis

Start: 2014-09-30End: 2018-12-31Target: 500Updated: 2018-07-19

To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer

TerminatedNCT05405439

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Metastatic Castration-resistant Prostate Cancer

Start: 2022-08-25End: 2023-07-19Updated: 2023-11-03

Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

RecruitingNCT05942001

Jiangsu HengRui Medicine Co., Ltd.Advanced Prostate Cancer

Start: 2023-08-03End: 2026-09-01Target: 100Updated: 2026-08-31

A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer

RecruitingNCT06568094

Jiangsu HengRui Medicine Co., Ltd.Prostate Cancer

Start: 2024-09-25End: 2027-06-01Target: 100Updated: 2026-06-10

A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone

RecruitingNCT06689163

Jiangsu HengRui Medicine Co., Ltd.Prostate Cancer

Start: 2024-12-11End: 2026-12-31Target: 66Updated: 2025-09-03

Phase 2

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

Hongqian GuoNeoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel

Start: 2018-12-12End: 2023-01-01Target: 75Updated: 2022-12-29

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

CompletedNCT04992026

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolAbiraterone, Oligometastatic Prostate Cancer, Prostatectomy

Start: 2021-01-01End: 2024-12-02Updated: 2024-12-05

A Study of BEBT-908 in Combination With Chemotherapy in Patients With Previously Untreated Peripheral T-Cell Lymphoma (PTCL)

Not yet recruitingNCT07676175

BeBetter Med IncPreviously Untreated Peripheral T-Cell Lymphoma

Start: 2026-07-01End: 2028-06-30Target: 120Updated: 2026-06-30

Unknown Phase

Takayasu Arteritis Clinical Trial in China

CompletedNCT02981979

Jiang lindiTakayasu Arteritis

Start: 2016-12-22End: 2022-11-22Updated: 2025-04-24

Related Papers

Efficacy of leflunomide in active Takayasu arteritis: a randomized double-blind placebo-controlled trial subtitle: Takayasu arteritis clinical trial in China (TACTIC)

BMC Medicine2026-07-03

HRS-5041, an androgen receptor degrader, in metastatic castration-resistant prostate cancer: A phase 1, multicenter, first-in-human study.

Journal of Clinical Oncology2026-05-27

HRS-1167 (M9466), a PARP1 inhibitor, combined with abiraterone acetate and prednisone in metastatic castration-resistant prostate cancer: A phase 1b/2 study.

Journal of Clinical Oncology2026-05-27

Androgen deprivation therapy plus abiraterone or docetaxel as neoadjuvant therapy for very-high-risk prostate cancer: a pooled analysis of two phase II trials

Frontiers in Pharmacology2023-06-2610 citations

A retrospective study to evaluate the effect of preoperative hormonal therapy on continence recovery

Frontiers in Oncology2023-01-13

Comparison of the efficacy and safety of leflunomide versus placebo combined with basic prednisone therapy in patients with active disease phase of Takayasu arteritis: study protocol for a randomized, double-blinded controlled trial (Takayasu arteritis clinical trial in China: TACTIC)

Therapeutic Advances in Chronic Disease2023-01-015 citations

Traditional Chinese medicine versus regular therapy in Henoch-Schönlein purpura nephritis in children: study protocol for a randomized controlled trial.

2019-08-2912 citations